Colorectal Cancer Survivors Suffering From Sensory Chemotherapy-Induced Peripheral Neuropathy Are Not a Homogenous Group: Secondary Analysis of Patients' Profiles With Oxaliplatin-Induced Peripheral Neuropathy

被引：5

作者：

Kerckhove, Nicolas ^{[1
,2
,3
]}

Selvy, Marie ^{[1
]}

Lambert, Celine ^{[2
]}

Gonneau, Coralie ^{[1
]}

Feydel, Gabrielle ^{[2
]}

Petorin, Caroline ^{[4
]}

Vimal-Baguet, Agnes ^{[4
]}

Melnikov, Sergey ^{[5
]}

Kullab, Sharif ^{[6
]}

Hebbar, Mohamed ^{[7
]}

Bouche, Olivier ^{[8
]}

Slimano, Florian ^{[9
]}

Bourgeois, Vincent ^{[10
]}

Lebrun-Ly, Valerie ^{[11
]}

Thuillier, Frederic ^{[11
]}

Mazard, Thibault ^{[12
]}

Tavan, David ^{[13
]}

Benmammar, Kheir Eddine ^{[14
]}

Monange, Brigitte ^{[14
]}

Ramdani, Mohamed ^{[15
]}

Pere-Verge, Denis ^{[16
]}

Huet-Penz, Floriane ^{[17
]}

Bedjaoui, Ahmed ^{[18
]}

Genty, Florent ^{[19
]}

Leyronnas, Cecile ^{[20
]}

Busserolles, Jerome ^{[1
,3
]}

Trevis, Sophie ^{[21
]}

Pinon, Vincent ^{[21
]}

Pezet, Denis ^{[22
]}

Balayssac, David ^{[1
,2
]}

机构：

[1] Univ Clermont Auvergne, INSERM U1107 NEURO DOL, Clermont Ferrand, France

[2] CHU Clermont Ferrand, Delegat Rech Clin & Innovat, Clermont Ferrand, France

[3] Univ Clermont Auvergne, Inst Analgesia, Clermont Ferrand, France

[4] CHU Clermont Ferrand, Serv Oncol Digest, Clermont Ferrand, France

[5] Ctr Hosp St Flour, Serv Chirurg Gen & Viscerale, St Flour, France

[6] Ctr Hosp Moulins Yzeure, Serv Oncol, Moulins, France

[7] CHRU Lille, Serv Oncol, Lille, France

[8] Univ Reims, Serv Oncol Digest, CHU Reims, Reims, France

[9] Univ Reims, Serv Pharm, SFR CAP Sante, BioSpect,CHU Reims, Reims, France

[10] Ctr Hosp Boulogne Sur Mer, Serv Oncol Digest, Boulogne Sur Mer, France

[11] CHU Limoges, Serv Oncol, Limoges, France

[12] Univ Montpellier, INSERM, IRCM, ICM, Montpellier, France

[13] Infirmerie Protestante Lyon, Serv Gastroenterol, Caluire Et Cuire, France

[14] Ctr Hosp Emile Roux, Serv Oncol, Le Puy En Velay, France

[15] Ctr Hosp Beziers, Serv Gastroenterol, Beziers, France

[16] Ctr Hosp St Joseph St Luc, Serv Hepatogastroenterol, Lyon, France

[17] Ctr Hosp Alpes Leman, Serv Gastro Enterol, Contamine Sur Arve, France

[18] Ctr Hosp Intercommunal Hop Leman, Serv Gastroenterol, Thonon Les Bains, France

[19] Ctr Hosp Vichy, Serv Chirurg Digest & Viscerale, Vichy, France

[20] Grp Hosp Mutualiste Grenoble, Serv Oncol, Grenoble, France

[21] CHU Clermont Ferrand, Serv Pharm, Clermont Ferrand, France

[22] Univ Clermont Auvergne, CHU Clermont Ferrand, USC INRA 2018, INSERM,M2iSH, Clermont Ferrand, France

来源：

FRONTIERS IN PHARMACOLOGY | 2021年 / 12卷

关键词：

chemotherapy-induced peripheral neuropathy; neuropathic pain; colorectal cancer; oxaliplatin; cluster analysis; NEUROTOXICITY; QUESTIONNAIRE; PREVENTION; GUIDELINES; RISK;

D O I：

10.3389/fphar.2021.744085

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Oxaliplatin, a pivotal drug in the management of colorectal cancer, causes chemotherapy-induced peripheral neuropathy (CIPN) in a third of cancer survivors. Based on a previous cross-sectional study assessing oxaliplatin-related sensory CIPN in colorectal cancer survivors, a secondary analysis was designed to explore the possibility that different clusters of patients may co-exist among a cohort of patients with oxaliplatin-related CIPN. Other objectives were to characterize these clusters considering CIPN severity, anxiety, depression, health-related quality of life (HRQOL), patients' characteristics and oxaliplatin treatments. Among the 96 patients analyzed, three clusters were identified (cluster 1: 52, cluster 2: 34, and cluster 3: 10 patients). Clusters were significantly different according to CIPN severity and the proportion of neuropathic pain (cluster 1: low, cluster 2: intermediate, and cluster 3: high). Anxiety, depressive disorders and HRQOL alteration were lower in cluster 1 in comparison to clusters 2 and 3, but not different between clusters 2 and 3. This study underlines that patients with CIPN are not a homogenous group, and that CIPN severity is associated with psychological distress and a decline of HRQOL. Further studies are needed to explore the relation between clusters and CIPN management.

引用

页数：10

共 50 条

[21] Oxaliplatin-Induced Peripheral Neuropathy and Identification of Unique Severity Groups in Colorectal Cancer
Griffith, Kathleen A.
Zhu, Shijun
Johantgen, Meg
Kessler, Michael D.
Renn, Cynthia
Beutler, Andreas S.
Kanwar, Rahul
Ambulos, Nicholas
Cavaletti, Guido
Bruna, Jordi
Briani, Chiara
Argyriou, Andreas A.
Kalofonos, Haralabos P.
Yerges-Armstrong, Laura M.
Dorsey, Susan G.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2017, 54 (05) : 701 - +
[22] Chemotherapy-Induced Peripheral Neuropathy
Brown, Timothy J.
Sedhom, Ramy
Gupta, Arjun
JAMA ONCOLOGY, 2019, 5 (05) : 750 - 750
[23] CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY
Ohno, Tsuyoshi
ANTICANCER RESEARCH, 2014, 34 (10) : 6085 - 6085
[24] Chemotherapy-induced peripheral neuropathy
Quasthoff, S
Grosskreutz, J
MEDIZINISCHE WELT, 2000, 51 (1-2): : 10 - 14
[25] Chemotherapy-induced peripheral neuropathy
Bushra Malik
Mark Stillman
Current Pain and Headache Reports, 2008, 12
[26] Chemotherapy-Induced Peripheral Neuropathy
Knoerl, Robert
AMERICAN JOURNAL OF NURSING, 2021, 121 (04) : 26 - 30
[27] Chemotherapy-induced peripheral neuropathy
Malik, Bushra
Stillman, Mark
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2008, 8 (01) : 56 - 65
[28] Chemotherapy-induced peripheral neuropathy
Stefan Quasthoff
Hans Peter Hartung
Journal of Neurology, 2002, 249 : 9 - 17
[29] Chemotherapy-induced peripheral neuropathy
Visovsky, C
CANCER INVESTIGATION, 2003, 21 (03) : 439 - 451
[30] Chemotherapy-induced peripheral neuropathy
Armstrong, T
Almadrones, L
Gilbert, MR
ONCOLOGY NURSING FORUM, 2005, 32 (02) : 305 - 311

← 1 2 3 4 5 →